Shingrix

Shingrix in Renal Transplant Recipients

A Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants

A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults

Safety and Immunogenicity of CVI-VZV-001 in Adults Aged 50 Years and Above

Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population

Vaccine Responses in Patients With B Cell Malignancies

Phase I Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above

Safety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adults 50 Years of Age and Over

A Phase 2 Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants

Safety and Immunogenicity of CRV-101 Vaccine for the Prevention of Herpes Zoster in Adults Aged 50 Years and Older

A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1468 in Healthy Adults ≥50 Years of Age

Clinical Trial to Evaluate EuHZV in Healthy Adults Aged 50 to 69 Years

VZV in the Enteric Nervous System: Pathogenesis and Consequences

VZV-specific Tissue Resident Memory T-cells After Shingrix Vaccination

Immunogenicity of Herpes Zoster Subunit Vaccine in Inflammatory Bowel Disease Patients Treated With Vedolizumab

A Phase 2 Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine

A Safety and Immunogenicity Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 50 to 70 Years

Shingrix Vaccine in Patients With Moderate to Severe Ulcerative Colitis on Tofacitinib

A Study Exploring the Use of Vaccine and Antigen Challenges for Immune Monitoring in Healthy Participants

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Herpes Zoster Vaccine